ZIMV News and Press, ZimVie Inc. From 04/01/24

2024-04-01 08:07:31 ET More on ZimVie ZimVie: Shrinking Its Way To Profitability ZimVie launches TSX dental implant product in Japan Read the full article on Seeking Alpha For further details see: H.I.G. Capital completes acquisition of the spine unit of ...

PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G. Capital for $375 million in total consid...

WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. Management will be presenting on Wednesd...

2024-02-28 19:30:12 ET Image source: The Motley Fool. ZimVie (NASDAQ: ZIMV) Q4 2023 Earnings Call Feb 28, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: ZimVie (ZIMV) Q4 2023 Earnings Call Transcript

FY 2023 Third Party Net Sales from Continuing Operations of $457.2 million FY 2023 Third Party Net Sales from Discontinued Operations of $409.2 million Updated Reporting Framework: Continuing Operations consists of the Dental Business and the majority of Corporate while Discontinu...

SilverBow Resorces Inc. (SBOW) is expected to report $2.36 for Q4 2023 FAT Brands Inc. Class B Common Stock (FATBB) is expected to report for quarter end 2023-12-31 Ecovyst Inc. (ECVT) is expected to report $0.2 for Q4 2023 MYR Group Inc. (MYRG) is expected to report $1.41 for Q4 2023...

2024-02-25 18:50:34 ET More on Enovis Corporation, Paragon 28, etc. Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript Enovis Corporation Non-GAAP EPS of $0.79 beats by $0.05, revenue of $455.02M beats by $9.63M Enovis Corporation Q4 2023 Earnings Preview ...

WESTMINSTER, Colo., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full-year 2023 after market close on Wednesday, February 28, 2024. Company managem...

2024-02-12 12:42:00 ET Summary ZimVie Inc. plans to divest its Spine business and focus on the higher growth Dental market. The Dental market only offers modest growth with increasing competition, though. The divestment of the Spine business will bring in cash and strengthen ZimVi...

2024-02-12 04:21:15 ET Summary In recent years, Alphatec Holdings has outperformed expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company is capitalizing on M&A-related disruptions at key competitors, w...